Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease
Public ClinicalTrials.gov record NCT03623321. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 52-Week Open-label Extension Study of Pimavanserin in Adult and Elderly Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease
Study identification
- NCT ID
- NCT03623321
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- ACADIA Pharmaceuticals Inc.
- Industry
- Enrollment
- 595 participants
Conditions and interventions
Interventions
- Pimavanserin Drug
Drug
Eligibility (public fields only)
- Age range
- 60 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 16, 2018
- Primary completion
- May 4, 2023
- Completion
- May 4, 2023
- Last update posted
- Dec 19, 2024
2018 – 2023
United States locations
- U.S. sites
- 17
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cognitive Clinical Trials | Gilbert | Arizona | 85296 | — |
| ATP Clinical Research, Inc. | Costa Mesa | California | 92626 | — |
| Syrentis Clinical Research | Santa Ana | California | 92705 | — |
| Indago Research & Health Center Inc | Hialeah | Florida | 33012 | — |
| Reliable Clinical Research, LLC | Hialeah | Florida | 33012 | — |
| Premier Clinical Research Institute, Inc. | Miami | Florida | 33122 | — |
| Global Medical Institutes | Miami | Florida | 33125 | — |
| Future Care Solution, LLC | Miami | Florida | 33165 | — |
| MediClear Medical & Research Center, Inc. | Miami | Florida | 33165 | — |
| Novel Clinical Research LLC | Miami | Florida | 33186 | — |
| Laszlo J Mate, MD, PA | North Palm Beach | Florida | 33408 | — |
| Synexus Clinical Research US, Inc. | The Villages | Florida | 32162 | — |
| The NeuroCognitive Institute | Mount Arlington | New Jersey | 07856 | — |
| UNC Hospital | Chapel Hill | North Carolina | 27599 | — |
| Insight Clinical Trials LLC | Shaker Heights | Ohio | 44122 | — |
| Suburban Research Associates | Media | Pennsylvania | 19063 | — |
| Central for Biomedical Research, LLC | Knoxville | Tennessee | 37909 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03623321, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2024 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03623321 live on ClinicalTrials.gov.